FindTrial
Sign In

Effect of professional team multi-channel health education on safety management of oral chemotherapy drugs for patients with hematological cancer

Effect of professional team multi-channel health education on safety management of oral chemotherapy drugs for patients with hematological cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053867
Enrollment
Unknown
Registered
2021-12-01
Start date
2022-11-10
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplastic Hematologic Disorder

Interventions

Intervention group:multi-channel health education
Control group:routine intervention

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Diagnosed by a doctor as hematological malignancies, including leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma; 3. The treatment plan contains oral chemotherapy drugs; 4. Clear consciousness, no language communication and reading comprehension barriers; 5. Informed consent, willing to participate in the research of this subject.

Exclusion criteria

Exclusion criteria: 1. Combined with serious heart, brain, kidney and other serious diseases or mental disorders; 2. Life is completely incapable of taking care of oneself and needs someone else to take care of.

Design outcomes

Primary

MeasureTime frame
Morisky Medication Adherence Scale;—

Secondary

MeasureTime frame
General information questionnaire;Oral chemotherapy drug related knowledge questionnaire;—

Countries

China

Contacts

Public ContactWang Jing

Peking University First Hospital

xiaoyu20120511@163.com+86 13426118287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026